194 related articles for article (PubMed ID: 15702820)
1. Use of 0.06% ipratropium bromide nasal spray in children aged 2 to 5 years with rhinorrhea due to a common cold or allergies.
Kim KT; Kerwin E; Landwehr L; Bernstein JA; Bruner D; Harris D; Drda K; Wanger J; Wood CC;
Ann Allergy Asthma Immunol; 2005 Jan; 94(1):73-9. PubMed ID: 15702820
[TBL] [Abstract][Full Text] [Related]
2. Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis.
Dockhorn R; Aaronson D; Bronsky E; Chervinsky P; Cohen R; Ehtessabian R; Finn A; Grossman J; Howland W; Kaiser H; Pearlman D; Sublett J; Ratner P; Settipane G; Sim T; Storms W; Webb R; Drda K; Wood C
Ann Allergy Asthma Immunol; 1999 Apr; 82(4):349-59. PubMed ID: 10227333
[TBL] [Abstract][Full Text] [Related]
3. Ipratropium bromide nasal spray 0.03% provides additional relief from rhinorrhea when combined with terfenadine in perennial rhinitis patients; a randomized, double-blind, active-controlled trial.
Finn AF; Aaronson D; Korenblat P; Lumry W; Settipane G; Spector S; Woehler T; Drda K; Wood CC
Am J Rhinol; 1998; 12(6):441-9. PubMed ID: 9883302
[TBL] [Abstract][Full Text] [Related]
4. Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: a study of its effect on their symptoms, quality of life, and nasal cytology.
Meltzer EO; Orgel HA; Bronsky EA; Findlay SR; Georgitis JW; Grossman J; Ratner P; Wood CC
J Allergy Clin Immunol; 1992 Aug; 90(2):242-9. PubMed ID: 1386857
[TBL] [Abstract][Full Text] [Related]
5. Long-term treatment of perennial allergic rhinitis with ipratropium bromide nasal spray 0.06%.
Kaiser HB; Findlay SR; Georgitis JW; Grossman J; Ratner PH; Tinkelman DG; Roszko P; Zegarelli E; Wood CC
J Allergy Clin Immunol; 1995 May; 95(5 Pt 2):1128-32. PubMed ID: 7751529
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of intranasal ipratropium bromide in common colds. A randomized, double-blind, placebo-controlled trial.
Hayden FG; Diamond L; Wood PB; Korts DC; Wecker MT
Ann Intern Med; 1996 Jul; 125(2):89-97. PubMed ID: 8678385
[TBL] [Abstract][Full Text] [Related]
7. The anticholinergic agent, ipratropium bromide, is useful in the treatment of rhinorrhea associated with perennial allergic rhinitis.
Kaiser HB; Findlay SR; Georgitis JW; Grossman J; Ratner PH; Tinkelman DG; Wood CC
Allergy Asthma Proc; 1998; 19(1):23-9. PubMed ID: 9532321
[TBL] [Abstract][Full Text] [Related]
8. A dose-response study of the efficacy and safety of ipratropium bromide nasal spray in the treatment of the common cold.
Diamond L; Dockhorn RJ; Grossman J; Kisicki JC; Posner M; Zinny MA; Koker P; Korts D; Wecker MT
J Allergy Clin Immunol; 1995 May; 95(5 Pt 2):1139-46. PubMed ID: 7751531
[TBL] [Abstract][Full Text] [Related]
9. Ipratropium nasal spray in children with perennial rhinitis.
Meltzer EO; Orgel HA; Biondi R; Georgitis J; Milgrom H; Munk Z; Van Bavel J; Wood CC; Drda K
Ann Allergy Asthma Immunol; 1997 May; 78(5):485-91. PubMed ID: 9164362
[TBL] [Abstract][Full Text] [Related]
10. Ipratropium bromide nasal spray in non-allergic rhinitis: efficacy, nasal cytological response and patient evaluation on quality of life.
Georgitis JW; Banov C; Boggs PB; Dockhorn R; Grossman J; Tinkelman D; Roszko P; Wood C
Clin Exp Allergy; 1994 Nov; 24(11):1049-55. PubMed ID: 7874603
[TBL] [Abstract][Full Text] [Related]
11. A clinical trial of ipratropium bromide nasal spray in patients with perennial nonallergic rhinitis.
Bronsky EA; Druce H; Findlay SR; Hampel FC; Kaiser H; Ratner P; Valentine MD; Wood CC
J Allergy Clin Immunol; 1995 May; 95(5 Pt 2):1117-22. PubMed ID: 7751528
[TBL] [Abstract][Full Text] [Related]
12. Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold.
Eccles R; Martensson K; Chen SC
Curr Med Res Opin; 2010 Apr; 26(4):889-99. PubMed ID: 20151787
[TBL] [Abstract][Full Text] [Related]
13. Ipratropium bromide (Atrovent nasal spray) reduces the nasal response to methacholine.
Baroody FM; Majchel AM; Roecker MM; Roszko PJ; Zegarelli EC; Wood CC; Naclerio RM
J Allergy Clin Immunol; 1992 Jun; 89(6):1065-75. PubMed ID: 1535082
[TBL] [Abstract][Full Text] [Related]
14. Ipratropium nasal spray: a new treatment for rhinorrhea in the common cold.
Borum P; Olsen L; Winther B; Mygind N
Am Rev Respir Dis; 1981 Apr; 123(4 Pt 1):418-20. PubMed ID: 6452842
[TBL] [Abstract][Full Text] [Related]
15. Intranasal anticholinergic therapy of rhinorrhea.
Meltzer EO
J Allergy Clin Immunol; 1992 Dec; 90(6 Pt 2):1055-64. PubMed ID: 1460208
[TBL] [Abstract][Full Text] [Related]
16. OTC use of a topical nasal spray solution containing xylometazoline plus ipratropium in patients with common cold.
Strandell B; Norgren-Holst E; Tran N; Jakobsen HB; Chen S
Int J Clin Pharmacol Ther; 2009 Dec; 47(12):744-51. PubMed ID: 19954713
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, placebo-controlled study of the safety and efficacy of ipratropium bromide nasal spray versus placebo in patients with the common cold.
Dockhorn R; Grossman J; Posner M; Zinny M; Tinkleman D
J Allergy Clin Immunol; 1992 Dec; 90(6 Pt 2):1076-82. PubMed ID: 1460211
[TBL] [Abstract][Full Text] [Related]
18. A time-dose study of the effect of topical ipratropium bromide on methacholine-induced rhinorrhoea in patients with perennial non-allergic rhinitis.
Becker B; Borum S; Nielsen K; Mygind N; Borum P
Clin Otolaryngol Allied Sci; 1997 Apr; 22(2):132-4. PubMed ID: 9160925
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of intranasal xylometazoline and ipratropium in patients with common cold.
Graf P; Eccles R; Chen S
Expert Opin Pharmacother; 2009 Apr; 10(5):889-908. PubMed ID: 19351236
[TBL] [Abstract][Full Text] [Related]
20. Product characteristics and pharmacokinetics of intranasal ipratropium bromide.
Wood CC; Fireman P; Grossman J; Wecker M; MacGregor T
J Allergy Clin Immunol; 1995 May; 95(5 Pt 2):1111-6. PubMed ID: 7751527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
